35975-17-8

Usage

Chemical structure

Piperazine derivative with a benzyl group attached to the nitrogen atom

Appearance

White crystalline

Solubility

Soluble in organic solvents such as ethanol and dimethyl sulfoxide

Anticonvulsant effects

Potential to reduce or prevent seizures

Anxiolytic effects

Potential to reduce anxiety and stress

Synthesis

Investigated as a precursor in the synthesis of other compounds

Safety

Proper handling and usage guidelines should be followed to ensure safety and minimize potential risks

Upstream product

• 871893-10-6 N,N-di(carbamoylmethyl)benzylamine 
• 3987-53-9 N-benzyliminodiacetic acid 
• 100-44-7 benzyl chloride 
• 6175-26-4 dimethyl 2,2′-(benzylazanediyl)diacetate 
• 16728-92-0 N-benzyl-N,N-bis(cyanomethyl)amine 
• 100-46-9 benzylamine 

Downstream Products

• 118220-96-5 1-benzyl[3,3,5,5-2H₄]piperazine 
• 35975-30-5 piperazine-2,6-dione hydrochloride 

Relevant academic research and scientific papers

NOVEL ACYLPIPERAZINONES AND THEIR USE AS PHARMACEUTICALS

The invention relates to novel acylpiperazinone compounds, to the preparation of the compounds and intermediates used therein, to the use of the compounds as antibacterial medicaments and pharmaceutical compositions containing the compounds.

PYRAZOLE DERIVATIVES

A compound represented by formula (I): (wherein Ar1 represents a phenyl group which may have 1 to 3 substituents, or a non-substituted 5- or 6-membered aromatic heterocyclic group; Ar2 represents (i) a non-substituted phenyl group, (ii) a phenyl group which has been substituted by a lower alkyl group having 1 to 3 groups or atoms selected from among a carbamoyl group, an amino group, a hydroxyl group, a lower alkoxy group, and a halogen atom, or (iii) a 5- or 6-membered nitrogen-containing aromatic heterocyclic group which has been substituted by 1 to 3 groups or atoms selected from among a lower alkyl group, a lower alkynyl group, a lower alkanoyl group, a carbamoyl group, a cyano group, an amino group, a hydroxyl group, a lower alkoxy group, and a halogen atom; and X represents a group represented by formula (II): (wherein the ring structure represents a 4- to 7-membered heterocyclic group which may have, in addition to the nitrogen atom shown in formula (II), one heteroatom selected from among nitrogen, oxygen, and sulfur, and which may be substituted by 1 to 4 groups or atoms selected from among a lower alkyl group, a carbamoyl group, an amino group, a hydroxyl group, a lower alkoxy group, an oxo group, a lower alkanoyl group, a lower alkylsulfonyl group, and a halogen atom)), a salt thereof, a solvate of the compound or the salt, and a drug.